awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35095308-011D1122-26DC-4B68-AE06-8B7CBF8A1111
Q35095308-011D1122-26DC-4B68-AE06-8B7CBF8A1111
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35095308-011D1122-26DC-4B68-AE06-8B7CBF8A1111
PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup
P2860
Q35095308-011D1122-26DC-4B68-AE06-8B7CBF8A1111
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35095308-011D1122-26DC-4B68-AE06-8B7CBF8A1111
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d3dddbe30a3ebdb3ad7572bfa4aac1b290f1a15a
P2860
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)